{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:06Z","timestamp":1791395526209,"version":"4.3.3"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09032212110062"],"award-info":[{"award-number":["09032212110062"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Assisted Reproductive Technology (ART) increases the risk of preeclampsia (PE), yet no specific prediction model tailored to the ART population exists. This review evaluates prediction models incorporating ART as a predictor, focusing on risk of bias, performance, generalizability and clinical applicability. A systematic MEDLINE search up to July 2023 identified models predicting PE that included ART as a predictor. Exclusion comprised studies on outcomes after PE onset, univariable models and validation studies of previously validated models. Risk of bias, applicability and generalizability were assessed using the Prediction model Risk Of Bias ASsessment Tool (PROBAST) and the Transparent Reporting of a multivariable prediction model for Individual Prognosis and Diagnosis (TRIPOD) guideline. Out of 15,305 records, 161 articles were assessed in full-text, yielding fifteen eligible studies. Eleven studies were added from a prior systematic review. Performance varied widely (AUC 0.58\u20130.99) and only few (7\/26) models had been externally validated. Risk of bias was unclear in most studies (21\/26), due to analytical issues. Despite ART being an established risk factor for PE, robust and generalizable models with proven external validity are lacking. Future research should prioritize development of a high quality prediction model including ART, or a model developed specifically within ART populations.<\/jats:p>","DOI":"10.1007\/s43032-026-02168-7","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:17:02Z","timestamp":1789485422000},"page":"1907-1930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assisted Reproductive Technology as Predictor for Preeclampsia: A Systematic Review of Current Clinical Prediction Models"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-6921","authenticated-orcid":false,"given":"G\u00e9raldine C. M.","family":"Lafeber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-7815","authenticated-orcid":false,"given":"Marie-Louise P.","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2154-4923","authenticated-orcid":false,"given":"Saskia","family":"le Cessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-2294","authenticated-orcid":false,"given":"Eileen E. L. O.","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"12","key":"2168_CR1","first-page":"2321","volume":"38","author":"J Smeenk","year":"2019","unstructured":"European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Smeenk J, Wyns C, De Geyter C, Kupka M, Bergh C, et al. ART in Europe, 2019: results generated from European registries by ESHRE. Hum Reprod. 2019;38(12):2321\u201338.","journal-title":"Hum Reprod"},{"issue":"5","key":"2168_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/humupd\/dms018","volume":"18","author":"S Pandey","year":"2012","unstructured":"Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF\/ICSI: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(5):485\u2013503.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"2168_CR3","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1161\/HYPERTENSIONAHA.122.19689","volume":"80","author":"SH Petersen","year":"2023","unstructured":"Petersen SH, Westvik-Johari K, Spangmose AL, Pinborg A, Romundstad LB, Bergh C, et al. Risk of hypertensive disorders in pregnancy after fresh and frozen embryo transfer in assisted reproduction: a population-based cohort study with within-sibship analysis. Hypertension. 2023;80(2):e6-16.","journal-title":"Hypertension"},{"issue":"1","key":"2168_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03938-8","volume":"21","author":"HJ Chih","year":"2021","unstructured":"Chih HJ, Elias FTS, Gaudet L, Velez MP. Assisted reproductive technology and hypertensive disorders of pregnancy: systematic review and meta-analyses. BMC Pregnancy Childbirth. 2021;21(1):449.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2168_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"key":"2168_CR6","unstructured":"World Health Organization. Maternal mortality: Key facts. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/maternal-mortality. Accessed at 03 December 2024."},{"key":"2168_CR7","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Available from: https:\/\/www.nice.org.uk\/guidance\/ng133. Accessed at 12 January 2025."},{"issue":"10022","key":"2168_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387(10022):999\u20131011.","journal-title":"Lancet"},{"key":"2168_CR9","doi-asserted-by":"publisher","unstructured":"Patr\u00edcia Medeiros Falc\u00e3o K, Pedrozo Campos Antunes T, Do Nascimento Andrade Feitosa A, Victor EG, Nunes Alves de Sousa M, de Abreu LC et al. Association between hypertension and quality of life in pregnancy. Hypertension in Pregnancy. 2016;35(3):306\u2013314. https:\/\/doi.org\/10.3109\/10641955.2016.1143485","DOI":"10.3109\/10641955.2016.1143485"},{"issue":"5","key":"2168_CR10","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/humupd\/dmw012","volume":"22","author":"VM Savasi","year":"2016","unstructured":"Savasi VM, Mandia L, Laoreti A, Cetin I. Maternal and fetal outcomes in oocyte donation pregnancies. Hum Reprod Update. 2016;22(5):620\u201333.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"2168_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/1471-0528.14257","volume":"124","author":"M Storgaard","year":"2017","unstructured":"Storgaard M, Loft A, Bergh C, Wennerholm UB, S\u00f6derstr\u00f6m-Anttila V, Romundstad LB, et al. Obstetric and neonatal complications in pregnancies conceived after oocyte donation: a systematic review and meta-analysis. BJOG. 2017;124(4):561\u201372.","journal-title":"BJOG"},{"issue":"6","key":"2168_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/humupd\/dmq017","volume":"16","author":"ML van der Hoorn","year":"2010","unstructured":"van der Hoorn ML, Lashley EE, Bianchi DW, Claas FH, Schonkeren CM, Scherjon SA. Clinical and immunologic aspects of egg donation pregnancies: a systematic review. Hum Reprod Update. 2010;16(6):704\u201312.","journal-title":"Hum Reprod Update"},{"key":"2168_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.preghy.2019.03.005","volume":"16","author":"AC De Kat","year":"2019","unstructured":"De Kat AC, Hirst J, Woodward M, Kennedy S, Peters SA. Prediction models for preeclampsia: a systematic review. Pregnancy Hypertens. 2019;16:48\u201366.","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"2168_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses","year":"2009","unstructured":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The PRISMA Statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"2168_CR15","volume-title":"Assisted reproductive technology (ART) techniques","author":"M Jain","year":"2025","unstructured":"Jain M, Singh M. Assisted reproductive technology (ART) techniques. New York City, New York: StatPearls Publishing; 2025."},{"issue":"9761","key":"2168_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","volume":"377","author":"P von Dadelszen","year":"2011","unstructured":"von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, C\u00f4t\u00e9 AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219\u201327.","journal-title":"Lancet"},{"key":"2168_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.preghy.2018.06.017","volume":"13","author":"I Herraiz","year":"2018","unstructured":"Herraiz I, Sim\u00f3n E, G\u00f3mez-Arriaga PI, Quezada MS, Garc\u00eda-Burguillo A, L\u00f3pez-Jim\u00e9nez EA, et al. Clinical implementation of the sFlt-1\/PlGF ratio to identify preeclampsia and fetal growth restriction: a prospective cohort study. Pregnancy Hypertens. 2018;13:279\u201385.","journal-title":"Pregnancy Hypertens"},{"issue":"1","key":"2168_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51\u20138.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2168_CR19","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-1377","volume":"170","author":"KGM Moons","year":"2019","unstructured":"Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration. Ann Intern Med. 2019;170(1):W1\u201333.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2168_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","volume":"131","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD). Circulation. 2015;131(2):211\u20139.","journal-title":"Circulation"},{"key":"2168_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856231","volume":"12","author":"RC Bahar","year":"2022","unstructured":"Bahar RC, Merkaj S, Cassinelli Petersen GI, Tillmanns N, Subramanian H, Brim WR, et al. Machine learning models for classifying high- and low-grade gliomas: a systematic review and quality of reporting analysis. Front Oncol. 2022;12:856231.","journal-title":"Front Oncol"},{"issue":"9","key":"2168_CR22","doi-asserted-by":"publisher","first-page":"e041537","DOI":"10.1136\/bmjopen-2020-041537","volume":"10","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi AH, Ramspek CL, Dekker FW, Heus P, Hooft L, Moons KGM, et al. TRIPOD statement: a preliminary pre-post analysis of reporting and methods of prediction models. BMJ Open. 2020;10(9):e041537.","journal-title":"BMJ Open"},{"issue":"2","key":"2168_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.xfnr.2022.02.002","volume":"3","author":"A Youssef","year":"2022","unstructured":"Youssef A, van der Hoorn M-L, van Lith JMM, van Eekelen R, du Foss\u00e9 NA, Lashley LEELO. Prognosis in unexplained recurrent pregnancy loss: a systematic review and quality assessment of current clinical prediction models. F&S Reviews. 2022;3(2):136\u201345.","journal-title":"F&S Reviews"},{"issue":"10","key":"2168_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001744","volume":"11","author":"KGM Moons","year":"2014","unstructured":"Moons KGM, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.","journal-title":"PLoS Med"},{"issue":"1","key":"2168_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","journal-title":"Epidemiology"},{"key":"2168_CR26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"5","key":"2168_CR27","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ijrobp.2021.12.011","volume":"112","author":"I Fornacon-Wood","year":"2022","unstructured":"Fornacon-Wood I, Mistry H, Johnson-Hart C, Faivre-Finn C, O\u2019Connor JPB, Price GJ. Understanding the differences between Bayesian and frequentist statistics. Int J Radiat Oncol Biol Phys. 2022;112(5):1076\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2168_CR28","doi-asserted-by":"publisher","first-page":"383.e1","DOI":"10.1016\/j.ajog.2010.06.014","volume":"203","author":"F Audibert","year":"2010","unstructured":"Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010;203(4):383.e1-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2168_CR29","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41440-023-01298-8","volume":"46","author":"Y Chen","year":"2023","unstructured":"Chen Y, Huang X, Wu S, Guo P, Huang J, Zhou L, et al. Machine-learning predictive model of pregnancy-induced hypertension in the first trimester. Hypertens Res. 2023;46(9):2135\u201344.","journal-title":"Hypertens Res"},{"issue":"4","key":"2168_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41440-020-00558-1","volume":"44","author":"CY Yue","year":"2021","unstructured":"Yue CY, Gao JP, Zhang CY, Ni YH, Ying CM. Development and validation of a nomogram for the early prediction of preeclampsia in pregnant Chinese women. Hypertens Res. 2021;44(4):417\u201325.","journal-title":"Hypertens Res"},{"issue":"2","key":"2168_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.121.18021","volume":"79","author":"N Chaiyasit","year":"2022","unstructured":"Chaiyasit N, Sahota DS, Ma R, Choolani M, Wataganara T, Sim WS, et al. Prospective evaluation of International Prediction of Pregnancy Complications Collaborative Network models for prediction of preeclampsia: role of serum sFlt-1 at 11\u201313 weeks\u2019 gestation. Hypertension. 2022;79(2):314\u201322.","journal-title":"Hypertension"},{"issue":"1","key":"2168_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/uog.23528","volume":"57","author":"I Sapantzoglou","year":"2021","unstructured":"Sapantzoglou I, Wright A, Arozena MG, Campos RV, Charakida M, Nicolaides KH. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2021;57(1):75\u201383.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"2168_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/10641955.2016.1242605","volume":"36","author":"R Maymon","year":"2017","unstructured":"Maymon R, Trahtenherts A, Svirsky R, Melcer Y, Madar-Shapiro L, Klog E, et al. Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies. Hypertens Pregnancy. 2017;36(1):108\u201315.","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"2168_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/uog.17531","volume":"50","author":"C Francisco","year":"2017","unstructured":"Francisco C, Wright D, Benk\u0151 Z, Syngelaki A, Nicolaides KH. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2017;50(5):589\u201395.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"2168_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/uog.17529","volume":"50","author":"C Francisco","year":"2017","unstructured":"Francisco C, Wright D, Benk\u0151 Z, Syngelaki A, Nicolaides KH. Competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2017;50(4):501\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"2168_CR36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/uog.27451","volume":"62","author":"S Moungmaithong","year":"2023","unstructured":"Moungmaithong S, Wang X, Lau CSL, Tse AWT, Lee NMW, Leung HHY, et al. Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2023;62(4):512\u201321.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"2168_CR37","doi-asserted-by":"publisher","first-page":"e0225716","DOI":"10.1371\/journal.pone.0225716","volume":"14","author":"A Sandstr\u00f6m","year":"2019","unstructured":"Sandstr\u00f6m A, Snowden JM, H\u00f6ijer J, Bottai M, Wikstr\u00f6m AK. Clinical risk assessment in early pregnancy for preeclampsia in nulliparous women: A population based cohort study. PLoS ONE. 2019;14(11):e0225716.","journal-title":"PLoS ONE"},{"key":"2168_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092681","author":"M Lewandowska","year":"2020","unstructured":"Lewandowska M, Wi\u0119ckowska B, Sajdak S, Lubi\u0144ski J. Pre-pregnancy obesity vs. other risk factors in probability models of preeclampsia and gestational hypertension. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12092681.","journal-title":"Nutrients"},{"issue":"1","key":"2168_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jogc.2020.06.011","volume":"43","author":"A Boutin","year":"2021","unstructured":"Boutin A, Gasse C, Guerby P, Gigu\u00e8re Y, T\u00e9tu A, Bujold E. First-trimester preterm preeclampsia screening in nulliparous women: the Great Obstetrical Syndrome (GOS) Study. J Obstet Gynaecol Can. 2021;43(1):43\u20139.","journal-title":"J Obstet Gynaecol Can"},{"key":"2168_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.preghy.2021.10.006","volume":"26","author":"YX Li","year":"2021","unstructured":"Li YX, Shen XP, Yang C, Cao ZZ, Du R, Yu MD, et al. Novel electronic health records applied for prediction of pre-eclampsia: machine-learning algorithms. Pregnancy Hypertens. 2021;26:102\u20139.","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"2168_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/ajh\/hpab156","volume":"35","author":"H P\u00e9tursd\u00f3ttir Maack","year":"2022","unstructured":"P\u00e9tursd\u00f3ttir Maack H, Sundstr\u00f6m Poromaa I, Segeblad B, Lindstr\u00f6m L, Jonsson M, Junus K, et al. Waist circumference measurement for prediction of preeclampsia: a population-based cohort study. Am J Hypertens. 2022;35(2):200\u20136.","journal-title":"Am J Hypertens"},{"issue":"3","key":"2168_CR42","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/HJH.0000000000003336","volume":"41","author":"J Nurkkala","year":"2023","unstructured":"Nurkkala J, Kauko A, FinnGen Laivuori H, Saarela T, Tyrmi JS, et al. Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy. J Hypertens. 2023;41(3):380\u20137.","journal-title":"J Hypertens"},{"key":"2168_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065177","author":"I Hromadnikova","year":"2023","unstructured":"Hromadnikova I, Kotlabova K, Krofta L. First-trimester screening for HELLP syndrome-prediction model based on microRNA biomarkers and maternal clinical characteristics. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24065177.","journal-title":"Int J Mol Sci"},{"key":"2168_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11051327","author":"MN Nan","year":"2023","unstructured":"Nan MN, Garc\u00eda-Osuna \u00c1, Mora J, Trilla C, Antonijuan A, Orantes V, et al. Impact of angiogenic and cardiovascular biomarkers for prediction of placental dysfunction in the first trimester of pregnancy. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11051327.","journal-title":"Biomedicines"},{"issue":"5","key":"2168_CR45","doi-asserted-by":"publisher","first-page":"553.e1","DOI":"10.1016\/j.ajog.2023.05.015","volume":"229","author":"S Zhou","year":"2023","unstructured":"Zhou S, Li J, Yang W, Xue P, Yin Y, Wang Y, et al. Noninvasive preeclampsia prediction using plasma cell-free RNA signatures. Am J Obstet Gynecol. 2023;229(5):553.e1.","journal-title":"Am J Obstet Gynecol"},{"key":"2168_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/life13081648","author":"Y Xue","year":"2023","unstructured":"Xue Y, Yang N, Gu X, Wang Y, Zhang H, Jia K. Risk prediction model of early-onset preeclampsia based on risk factors and routine laboratory indicators. Life (Basel). 2023. https:\/\/doi.org\/10.3390\/life13081648.","journal-title":"Life (Basel)"},{"issue":"5","key":"2168_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/uog.7439","volume":"34","author":"LC Poon","year":"2009","unstructured":"Poon LC, Karagiannis G, Leal A, Romero XC, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11\u201313 weeks. Ultrasound Obstet Gynecol. 2009;34(5):497\u2013502.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"2168_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000338470","volume":"32","author":"D Wright","year":"2012","unstructured":"Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH. A competing risks model in early screening for preeclampsia. Fetal Diagn Ther. 2012;32(3):171\u20138.","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"2168_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/uog.11183","volume":"40","author":"A Khalil","year":"2012","unstructured":"Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH. Maternal hemodynamics at 11\u201313 weeks\u2019 gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol. 2012;40(1):28\u201334.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"2168_CR50","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ajo.12126","volume":"53","author":"FJ Park","year":"2013","unstructured":"Park FJ, Leung CH, Poon LC, Williams PF, Rothwell SJ, Hyett JA. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Aust N Z J Obstet Gynaecol. 2013;53(6):532\u20139.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"13","key":"2168_CR51","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1111\/1471-0528.13194","volume":"122","author":"RB Skr\u00e5stad","year":"2015","unstructured":"Skr\u00e5stad RB, Hov GG, Blaas HG, Romundstad PR, Salvesen K. Risk assessment for preeclampsia in nulliparous women at 11\u201313 weeks gestational age: prospective evaluation of two algorithms. BJOG. 2015;122(13):1781\u20138.","journal-title":"BJOG"},{"issue":"1","key":"2168_CR52","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","volume":"214","author":"N O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation. Am J Obstet Gynecol. 2016;214(1):103.e1-e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2168_CR53","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.17399","volume":"49","author":"N O'Gorman","year":"2017","unstructured":"O\u2019Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation. Ultrasound Obstet Gynecol. 2017;49(6):751\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"2168_CR54","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/jhh.2009.45","volume":"24","author":"LC Poon","year":"2010","unstructured":"Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104\u201310.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2168_CR55","doi-asserted-by":"publisher","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","volume":"213","author":"D Wright","year":"2015","unstructured":"Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2168_CR56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/uog.17373","volume":"50","author":"A Perales","year":"2017","unstructured":"Perales A, Delgado JL, de la Calle M, Garc\u00eda-Hern\u00e1ndez JA, Escudero AI, Campillos JM, et al. sFlt-1\/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain). Ultrasound Obstet Gynecol. 2017;50(3):373\u201382.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"2168_CR57","doi-asserted-by":"publisher","first-page":"e97230","DOI":"10.1371\/journal.pone.0097230","volume":"9","author":"X Li","year":"2014","unstructured":"Li X, Shen L, Tan H. Polymorphisms and plasma level of transforming growth factor-Beta 1 and risk for preeclampsia: a systematic review. PloS one. 2014;9(5):e97230.","journal-title":"PloS one"},{"key":"2168_CR58","doi-asserted-by":"crossref","unstructured":"Kalbfleisch JD PR. The Statistical Analysis of Failure of Time. John Wiley & Sons Inc, 2002.","DOI":"10.1002\/9781118032985"},{"issue":"1","key":"2168_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive Disorders of Pregnancy. Hypertension. 2018;72(1):24\u201343.","journal-title":"Hypertension"},{"key":"2168_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejogrb.2022.07.025","volume":"276","author":"J Augusto","year":"2022","unstructured":"Augusto J, Margarida PA. Preeclampsia risk in oocyte donation versus double gamete donation pregnancies: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022;276:219\u201327.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2168_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/pd.2440","volume":"30","author":"LCY Poon","year":"2010","unstructured":"Poon LCY, Stratieva V, Piras S, Piri S, Nicolaides KH. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11\u201313 weeks. Prenat Diagn. 2010;30(3):216\u201323.","journal-title":"Prenat Diagn"},{"issue":"6, Part 1","key":"2168_CR62","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/0002-9378(91)91429-Z","volume":"164","author":"JN Martin","year":"1991","unstructured":"Martin JN, Blake PG, Perry KG, McCaul JF, Hess LW, Martin RW. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol. 1991;164(6, Part 1):1500\u201313.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2168_CR63","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.clp.2004.06.007","volume":"31","author":"BM Sibai","year":"2004","unstructured":"Sibai BM. Imitators of severe pre-eclampsia\/eclampsia. Clin Perinatol. 2004;31(4):835\u201352.","journal-title":"Clin Perinatol"},{"issue":"7","key":"2168_CR64","doi-asserted-by":"publisher","first-page":"e079394","DOI":"10.1136\/bmjopen-2023-079394","volume":"14","author":"GCM Lafeber","year":"2024","unstructured":"Lafeber GCM, Van der Endt VHW, Louwers Y, le Cessie S, van der Hoorn MP, Lashley E. Development of the DONOR prediction model on the risk of hypertensive complications in oocyte donation pregnancy: study protocol for a multicentre cohort study in the Netherlands. BMJ Open. 2024;14(7):e079394.","journal-title":"BMJ Open"},{"issue":"S1","key":"2168_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019;145(S1):1\u201333.","journal-title":"Int J Gynecol Obstet"},{"key":"2168_CR66","doi-asserted-by":"publisher","DOI":"10.3109\/10641950109152635","author":"MA Brown","year":"2001","unstructured":"Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001. https:\/\/doi.org\/10.3109\/10641950109152635.","journal-title":"Hypertens Pregnancy"},{"issue":"4","key":"2168_CR67","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/0002-9378(88)90090-7","volume":"158","author":"DA Davey","year":"1988","unstructured":"Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158(4):892\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2168_CR68","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","volume":"4","author":"LA Magee","year":"2014","unstructured":"Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014;4(2):105\u201345.","journal-title":"Pregnancy Hypertens"},{"key":"2168_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/uog.6280","volume":"33","author":"LC Poon","year":"2009","unstructured":"Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol. 2009;33:23\u201333.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"2168_CR70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8\u201315.","journal-title":"Fetal Diagn Ther"},{"key":"2168_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajog.2015.06.013","volume":"214","author":"CE Kleinrouweler","year":"2016","unstructured":"Kleinrouweler CE, Cheong-See FM, Collins GS, Kwee A, Thangaratinam S, Khan KS. Prognostic models in obstetrics: available, but far from applicable. Am J Obstet Gynecol. 2016;214:79\u201390.","journal-title":"Am J Obstet Gynecol"},{"key":"2168_CR72","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441.","journal-title":"BMJ"},{"key":"2168_CR73","unstructured":"Willink R, White R. Disentangling classical and Bayesian approaches to uncertainty analysis. New Zealand: Measurement Standards Laboratory. 2012. https:\/\/www.scribd.com\/document\/336247071\/Disentangling-uncertainty-v14-pdf. Accessed 10 Feb 2025."},{"key":"2168_CR74","doi-asserted-by":"crossref","unstructured":"Moons KGM, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98(9):691.","DOI":"10.1136\/heartjnl-2011-301247"},{"issue":"10","key":"2168_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001886","volume":"12","author":"TP Debray","year":"2015","unstructured":"Debray TP, Riley RD, Rovers MM, Reitsma JB, Moons KG. Individual participant data (IPD) meta-analyses of diagnostic and prognostic modeling studies: guidance on their use. PLoS Med. 2015;12(10):e1001886.","journal-title":"PLoS Med"},{"key":"2168_CR76","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jclinepi.2014.06.018","volume":"68","author":"TP Debray","year":"2015","unstructured":"Debray TP, Vergouwe Y, Koffijberg H, Nieboer D, Steyerberg EW, Moons KG. A new framework to enhance the interpretation of external validation studies of clinical prediction models. J Clin Epidemiol. 2015;68:279\u201389.","journal-title":"J Clin Epidemiol"},{"key":"2168_CR77","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605.","journal-title":"BMJ"},{"key":"2168_CR78","volume-title":"Clinical prediction models. A practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2009","unstructured":"Steyerberg EW. Clinical prediction models. A practical approach to development, validation, and updating. New York, NY: Springer; 2009."},{"issue":"2","key":"2168_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001381","volume":"10","author":"EW Steyerberg","year":"2013","unstructured":"Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.","journal-title":"PLoS Med"},{"issue":"3","key":"2168_CR80","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1179\/174313409X448543","volume":"17","author":"P Loughna","year":"2009","unstructured":"Loughna P, Chitty L, Evans T, Chudleigh T. Fetal size and dating: charts recommended for clinical obstetric practice. Ultrasound (Leeds). 2009;17(3):160\u20136.","journal-title":"Ultrasound (Leeds)"},{"issue":"7","key":"2168_CR81","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10815-016-0701-9","volume":"33","author":"A Bl\u00e1zquez","year":"2016","unstructured":"Bl\u00e1zquez A, Garc\u00eda D, Rodr\u00edguez A, Vassena R, Figueras F, Vernaeve V. Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis. J Assist Reprod Genet. 2016;33(7):855\u201363.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"2168_CR82","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ajog.2015.11.020","volume":"214","author":"P Masoudian","year":"2016","unstructured":"Masoudian P, Nasr A, de Nanassy J, Fung-Kee-Fung K, Bainbridge SA, El Demellawy D. Oocyte donation pregnancies and the risk of preeclampsia or gestational hypertension: a systematic review and metaanalysis. Am J Obstet Gynecol. 2016;214(3):328\u201339.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"2168_CR83","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s10815-019-01552-4","volume":"36","author":"J Moreno-Sepulveda","year":"2019","unstructured":"Moreno-Sepulveda J, Checa MA. Risk of adverse perinatal outcomes after oocyte donation: a systematic review and meta-analysis. J Assist Reprod Genet. 2019;36(10):2017\u201337.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"2168_CR84","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/1471-0528.13910","volume":"123","author":"YB Jeve","year":"2016","unstructured":"Jeve YB, Potdar N, Opoku A, Khare M. Donor oocyte conception and pregnancy complications: a systematic review and meta-analysis. BJOG Int J Obstet Gynaecol. 2016;123(9):1471\u201380.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"2168_CR85","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humrep\/deab267","volume":"37","author":"A Keukens","year":"2022","unstructured":"Keukens A, van Wely M, van der Meulen C, Mochtar MH. Pre-eclampsia in pregnancies resulting from oocyte donation, natural conception or IVF: a systematic review and meta-analysis. Hum Reprod. 2022;37(3):586\u201399.","journal-title":"Hum Reprod"},{"issue":"12","key":"2168_CR86","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1007\/s43032-021-00821-x","volume":"29","author":"ML van der Hoorn","year":"2022","unstructured":"van der Hoorn ML, van Bentem K, Lashley E. Evidence-based pre-pregnancy counseling for oocyte donation pregnancies: a systematic review and guide for physicians. Reprod Sci. 2022;29(12):3311\u201320.","journal-title":"Reprod Sci"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-026-02168-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-026-02168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:02:29Z","timestamp":1791392549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-026-02168-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":86,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1007\/s43032-026-02168-7","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This systematic review does not need ethical consent from any patient.","order":1,"name":"Ethics","label":"Ethical Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review was registered in PROSPERO (ID CRD420250477748) on the 11th of March 2025.","order":2,"name":"Ethics","label":"PROSPERO Registration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}